Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ramya Thota, Douglas B Johnson & Jeffrey A Sosman. (2015) Trametinib in the treatment of melanoma. Expert Opinion on Biological Therapy 15:5, pages 735-747.
Read now
Read now
Clive McCarthy & Edward Walker. (2014) Tropomyosin receptor kinase inhibitors: a patent update 2009 – 2013. Expert Opinion on Therapeutic Patents 24:7, pages 731-744.
Read now
Read now
Articles from other publishers (32)
Teja Ram, Ankit Kumar Singh, Adarsh Kumar, Harshwardhan Singh, Prateek Pathak, Maria Grishina, Habibullah Khalilullah, Mariusz Jaremko, Abdul-Hamid Emwas, Amita Verma & Pradeep Kumar. (2023) MEK inhibitors in cancer treatment: structural insights, regulation, recent advances and future perspectives. RSC Medicinal Chemistry 14:10, pages 1837-1857.
Crossref
Crossref
Ava Bachari, Nazim Nassar, Srinivasareddy Telukutla, Roby Zomer, Chaitali Dekiwadia, Terrence J. Piva & Nitin Mantri. (2023) In Vitro Antiproliferative Effect of Cannabis Extract PHEC-66 on Melanoma Cell Lines. Cells 12:20, pages 2450.
Crossref
Crossref
Johann E. Bedoya-Cardona, Marcela Rubio-Carrasquilla, Iliana M. Ramírez-Velásquez, Mario S. Valdés-Tresanco & Ernesto Moreno. (2023) Identifying Potential Molecular Targets in Fungi Based on (Dis)Similarities in Binding Site Architecture with Proteins of the Human Pharmacolome. Molecules 28:2, pages 692.
Crossref
Crossref
Surya K. De. 2023. Medicines for Cancer. Medicines for Cancer
205
411
.
Anaïs Paris, Nina Tardif, Francesca M Baietti, Cyrille Berra, Héloïse M Leclair, Eleonora Leucci, Marie‐Dominique Galibert & Sébastien Corre. (2022)
The
AhR‐SRC
axis as a therapeutic vulnerability in
BRAFi
‐resistant melanoma
. EMBO Molecular Medicine 14:12.
Crossref
Crossref
Ramon MartinezIIIIII, Weiliang Huang, Heather Buck, Samantha Rea, Amy E. Defnet, Maureen A. Kane & Paul Shapiro. (2022) Proteomic Changes in the Monolayer and Spheroid Melanoma Cell Models of Acquired Resistance to BRAF and MEK1/2 Inhibitors. ACS Omega 7:4, pages 3293-3311.
Crossref
Crossref
Sharad S. Singhal, Saumya Srivastava, Tamara Mirzapoiazova, David Horne, Sanjay Awasthi & Ravi Salgia. (2021) Targeting the mercapturic acid pathway for the treatment of melanoma. Cancer Letters 518, pages 10-22.
Crossref
Crossref
Mudasir Nabi Peerzada, Ernest Hamel, Ruoli Bai, Claudiu T. Supuran & Amir Azam. (2021) Deciphering the key heterocyclic scaffolds in targeting microtubules, kinases and carbonic anhydrases for cancer drug development. Pharmacology & Therapeutics 225, pages 107860.
Crossref
Crossref
Yadi Zhou, Junfei Zhao, Jiansong Fang, William Martin, Lang Li, Ruth Nussinov, Timothy A. Chan, Charis Eng & Feixiong Cheng. (2021) My personal mutanome: a computational genomic medicine platform for searching network perturbing alleles linking genotype to phenotype. Genome Biology 22:1.
Crossref
Crossref
Tadashi Honda & Iwao Ojima. 2021. The Curious World of Fluorinated Molecules. The Curious World of Fluorinated Molecules
241
276
.
Elizabeth D. Kim, Catherine D. Kim, Joseph Chaney & Sunyoung Kim. 2021. Encyclopedia of Biological Chemistry III. Encyclopedia of Biological Chemistry III
27
43
.
O. O. Ryabaya & A. A. Prokofieva. (2020) The interplay of autophagy and epithelial-to-mesenchymal transition in cancer progression. Advances in Molecular Oncology 7:2, pages 8-19.
Crossref
Crossref
O. O. Ryabaya, A. A. Prokofieva, D. A. Khochenkov, R. A. Akasov, S. V. Burov, E. A. Markvicheva & E. V. Stepanova. (2019) THE ROLE OF EPITHELIAL-TO-MESENCHYMAL TRANSITION AND AUTOPHAGY IN ANTITUMORAL RESPONSE OF MELANOMA CELL LINES TO TARGET INHIBITION OF MEK AND mTOR KINASES. Siberian journal of oncology 18:3, pages 54-63.
Crossref
Crossref
Cecilia Lezcano, Alexander N. Shoushtari, Charlotte Ariyan, Travis J. Hollmann & Klaus J. Busam. (2018) Primary and Metastatic Melanoma With NTRK Fusions. American Journal of Surgical Pathology 42:8, pages 1052-1058.
Crossref
Crossref
Benedict AnchangKara L. DavisHarris G. FienbergBrian D. Williamson, Sean C. BendallLoukia G. KaracostaRobert Tibshirani, Garry P. NolanSylvia K. Plevritis. (2018) DRUG-NEM: Optimizing drug combinations using single-cell perturbation response to account for intratumoral heterogeneity. Proceedings of the National Academy of Sciences 115:18.
Crossref
Crossref
Yao Huang, David J. Burns, Benjamin E. Rich, Ian A. MacNeil, Abhijit Dandapat, Sajjad M. Soltani, Samantha Myhre, Brian F. Sullivan, Carol A. Lange, Leo T. Furcht & Lance G. Laing. (2017) Development of a test that measures real-time HER2 signaling function in live breast cancer cell lines and primary cells. BMC Cancer 17:1.
Crossref
Crossref
Sonia G. Escobar, Mark H. Chin, Mark L. Sandberg & Han Xu. (2017) Isolation and Characterization of a Distinct Subpopulation from the WM115 Cell Line That Resembles In Vitro Properties of Melanoma Cancer Stem Cells. SLAS Discovery 22:5, pages 484-493.
Crossref
Crossref
Pabitra Mohan Behera & Anshuman Dixit. 2017. Drug Design: Principles and Applications. Drug Design: Principles and Applications
57
68
.
Shailender Bhatia, Anna C. Pavlick, Peter Boasberg, John A. Thompson, George Mulligan, Michael D. Pickard, Hélène Faessel, Bruce J. Dezube & Omid Hamid. (2016) A phase I study of the investigational NEDD8-activating enzyme inhibitor pevonedistat (TAK-924/MLN4924) in patients with metastatic melanoma. Investigational New Drugs 34:4, pages 439-449.
Crossref
Crossref
Klaus J. Busam, Ricardo E. Vilain, Trina Lum, Jonathan A. Busam, Travis J. Hollmann, Robyn P.M. Saw, Daniel C. Coit, Richard A. Scolyer & Thomas Wiesner. (2016) Primary and Metastatic Cutaneous Melanomas Express ALK Through Alternative Transcriptional Initiation. American Journal of Surgical Pathology 40:6, pages 786-795.
Crossref
Crossref
Zheng Zhao, Li Xie, Lei Xie & Philip E. Bourne. (2016) Delineation of Polypharmacology across the Human Structural Kinome Using a Functional Site Interaction Fingerprint Approach. Journal of Medicinal Chemistry 59:9, pages 4326-4341.
Crossref
Crossref
Yu Zhou, Jiang Wang, Zhanni Gu, Shuni Wang, Wei Zhu, José Luis Aceña, Vadim A. Soloshonok, Kunisuke Izawa & Hong Liu. (2016) Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas. Chemical Reviews 116:2, pages 422-518.
Crossref
Crossref
Mohammad Atefi, Bjoern Titz, Earl Avramis, Charles Ng, Deborah JL Wong, Amanda Lassen, Michael Cerniglia, Helena Escuin-Ordinas, David Foulad, Begonya Comin-Anduix, Thomas G Graeber & Antoni Ribas. (2015) Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma. Molecular Cancer 14:1.
Crossref
Crossref
Angel Chao, Chyong-Huey Lai, Yun-Shien Lee, Shir-Hwa Ueng, Chiao-Yun Lin & Tzu-Hao Wang. (2015) Molecular characteristics of endometrial cancer coexisting with peritoneal malignant mesothelioma in Li-Fraumeni-like syndrome. BMC Cancer 15:1.
Crossref
Crossref
Geetika Sethi, Youngjoo Kwon, Rebecca J. Burkhalter, Harsh B. Pathak, Rashna Madan, Sarah McHugh, Safinur Atay, Smruthi Murthy, Ossama W. Tawfik & Andrew K. Godwin. (2015) PTN signaling: Components and mechanistic insights in human ovarian cancer. Molecular Carcinogenesis 54:12, pages 1772-1785.
Crossref
Crossref
Gregory R. Kardos & Gavin P. Robertson. (2015) Therapeutic interventions to disrupt the protein synthetic machinery in melanoma. Pigment Cell & Melanoma Research 28:5, pages 501-519.
Crossref
Crossref
Steven Howard. 2015. Fragment-Based Drug Discovery. Fragment-Based Drug Discovery
153
176
.
Doriano Fabbro, Sandra W Cowan-Jacob & Henrik Moebitz. (2015) Ten things you should know about protein kinases: IUPHAR Review 14. British Journal of Pharmacology 172:11, pages 2675-2700.
Crossref
Crossref
S Senese, Y C Lo, D Huang, T A Zangle, A A Gholkar, L Robert, B Homet, A Ribas, M K Summers, M A Teitell, R Damoiseaux & J Z Torres. (2014) Chemical dissection of the cell cycle: probes for cell biology and anti-cancer drug development. Cell Death & Disease 5:10, pages e1462-e1462.
Crossref
Crossref
Hans Starz. (2014) Von der OP bis zur Immuntherapie. MMW - Fortschritte der Medizin 156:4, pages 41-44.
Crossref
Crossref
Soya S. Sam & Gregory J. Tsongalis. 2014. Molecular Testing in Cancer. Molecular Testing in Cancer
405
421
.
Michael Tronnier, Kristina Semkova, Uwe Wollina & Georgi Tchernev. (2013) Malignant melanoma: epidemiologic aspects, diagnostic and therapeutic approach. Wiener Medizinische Wochenschrift 163:15-16, pages 354-358.
Crossref
Crossref